首页> 外文期刊>Artificial cells, nanomedicine, and biotechnology. >Hemoglobin-based oxygen carrier attenuates cerebral damage by improving tissue oxygen preload in a dog model of cardiopulmonary bypass
【24h】

Hemoglobin-based oxygen carrier attenuates cerebral damage by improving tissue oxygen preload in a dog model of cardiopulmonary bypass

机译:基于血红蛋白的氧气载体通过改善体外循环狗模型中的组织氧气预负荷来减轻脑损伤

获取原文
获取原文并翻译 | 示例
       

摘要

In order to investigate whether hemoglobin-based oxygen carrier (HBOC) attenuates cardiopulmonary bypass (CPB)-induced cerebral damage. Male adult Beagle dogs were randomly divided into sham, control, and HBOC groups. After establishment of CPB model, hearts were arrested for 2 h and reperfused for 2 h. HBOC improved intracerebral O-2 tensions and reduced the releases of biomarkers for cerebral damage, including neuron-specific enolase and S100 beta in both cerebrospinal fluid and serum. Moreover, HBOC attenuated the releases of tumor necrosis factor-alpha and interleukin-1 beta after CPB. Therefore, our findings suggest that HBOC could reduce cerebral damage after CPB, which was probably associated with improvement of tissue O-2 preload.
机译:为了研究基于血红蛋白的氧气载体(HBOC)是否能减轻体外循环(CPB)引起的脑损伤。雄性成年比格犬随机分为假,对照组和HBOC组。建立CPB模型后,将心脏停搏2 h,然后再灌注2 h。 HBOC改善了脑内O-2张力并减少了脑损伤生物标志物的释放,包括脑脊液和血清中的神经元特异性烯醇酶和S100 beta。此外,HBOC减弱了CPB后肿瘤坏死因子-α和白介素-1β的释放。因此,我们的发现表明,HBOC可以减轻CPB后的脑损伤,这可能与组织O-2预紧力的改善有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号